Expansion & Capabilities Aurigene Pharmaceutical Services has recently expanded its facilities in Hyderabad, India, and the United States, enhancing its capacity for end-to-end drug development and commercial manufacturing, creating numerous opportunities to support clients at various stages of their pipeline.

Strategic Collaborations Recent partnerships with companies like Kainomyx and Edity Therapeutics demonstrate Aurigene's commitment to innovative drug discovery and development, positioning it as a potential partner for advanced therapies and niche pharmaceutical solutions.

Investment in Biologics The company's significant $40 million investment in biologics facilities indicates a focus on high-growth areas such as therapeutic proteins, antibodies, and viral vectors, offering opportunities to supply raw materials, manufacturing services, or technical support in these specialized segments.

Global Presence With cGMP manufacturing facilities located in India, the UK, Mexico, and the US, Aurigene provides a geographically diverse footprint that can cater to multinational clients seeking regional manufacturing solutions and expedite global drug launches.

Innovative Service Portfolio Aurigene's integrated services from medicinal chemistry to formulation and manufacturing, along with its technological stack including advanced data analytics and molecular tools, position it as a comprehensive partner for clients seeking end-to-end support in drug development, creating multiple sales opportunities across the pipeline stages.